Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol SPRC
- Company SciSparc Ltd.
- Price $0.29
- Changes Percentage 26.53
- Change 0.0608
- Day Low $0.23
- Day High $0.3
- Year High $14.22
- Year Low $0.21
- Market Cap $3,003,561
- Price Avg 50 EMA (D) $0.3
- Price Avg 200 EMA (D) $1.59
- Exchange NASDAQ
- Volume 4,824,492
- Average Volume 3,013,065
- Open $0.23
- Previous Close $0.23
- EPS -14.43
- PE -0.02
- Earnings Announcement 2023-08-07 04:00:00
- Shares Outstanding $10,357,108
Company brief: SCISPARC LTD. (SPRC )
- Healthcare
- Biotechnology
- Mr. Itschak Shrem
- https://scisparc.com
- IL
- N/A
- 08-30-2021
- IL0010951403
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.